Infliximab in the treatment of a child with cutaneous granulomas associated with ataxia telangiectasia
- 1 September 2011
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 65 (3) , 676-677
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics RegisterAnnals of the Rheumatic Diseases, 2009
- Etanercept treatment of cutaneous granulomas in common variable immunodeficiencyJournal of Allergy and Clinical Immunology, 2006
- Caseating granulomatous disease in common variable immunodeficiency treated with infliximabJournal of Allergy and Clinical Immunology, 2005
- Cutaneous granulomas associated with primary immunodeficiency disordersBritish Journal of Dermatology, 2005
- Interstitial lung disease in patients with ataxia‐telangiectasiaPediatric Pulmonology, 2005
- Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency--possible immunologic and clinical consequencesBlood, 1996